Malaria Treatment Market Forecast to 2028

Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Treatment (Prescription Medications, Vaccines, Diagnostic Tests, and Others), Drug Type (Branded and Generic), Route of Administration (Oral and Parenteral & Intravenous), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others), and End User (Hospitals, Specialty Clinics, Homecare, and Others)

Report Code : TIPRE00018229 | Region : Global | Industry : Pharmaceuticals | Published Date : 18/Nov/2022

The malaria treatment market is expected to grow from US$ 1,638.27 million in 2021 to US$ 2,291.49 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028.

The market for malaria treatment is growing due to the high prevalence of malaria in low-income countries and global malaria elimination programs initiated by international and national organizations. Also, the increasing number of launches of advanced diagnostic tools and rising research activities to provide effective therapeutics are further driving the growth of the market. However, factors such as a counterfeit antimalarial drug and subsequent drug resistance are restraining the market growth.

According to the World Health Organization (WHO), malaria is an acute febrile illness caused by plasmodium parasites, which spread through the bites of infected female Anopheles mosquitoes. Malaria is caused by five parasite species in humans, and two of these species—Plasmodium falciparum and P. vivax—pose the greatest threat. P. falciparum is the deadliest malarial parasite, and it is the most widespread one on the African continent. P. vivax is the dominant malarial parasite in most countries outside of sub-Saharan Africa. According to the World malaria report (WMR) 2020 by the WHO, 241 million cases of malaria were reported in 2020, compared to 227 million cases recorded in 2019. The number of deaths caused due to malaria reached 0.62 million in 2020, with an annual rise of 69,000 deaths. While approximately two-thirds of these deaths (47,000) were due to disruptions in healthcare services during the COVID-19 pandemic, the remaining one-third of deaths (22,000) reflected a recent change in WHO’s methodology for calculating malaria mortality (irrespective of COVID-19 disruptions). As per the WHO, Africa continues to account for a disproportionately high share of the global burden of malaria. In 2020, 95% of the global cases of malaria and 96% of deaths were reported in Africa; ~80% of the total deaths caused by malaria are reported in children below 5 years of age. Four African countries—Nigeria (31.9%), the Democratic Republic of the Congo (13.2%), the United Republic of Tanzania (4.1%), and Mozambique (3.8%)—accounted for nearly half of all malaria-related deaths reported worldwide. According to the LANCET Regional Health 2020, the burden of malaria is the highest in African countries (95%); P. falciparum is the cause of the brunt of mortality in children younger than 5 (∼77%) across the world, and in African countries, this species accounts for ∼96% of total mortalities caused among children by malaria. Furthermore, P. vivax has been a causal agent of 2% (4.5 million) of the total cases, mostly from Asia. According to WMR 2021, ∼2% of the global burden of malaria is borne by Southeast Asian countries, and India contributed 83% of estimated malaria cases and 82% of malaria deaths in Southeast Asia in 2020. Hence, the rising prevalence of malaria in different regions of the world boosts the malaria treatment market growth.

Treatment-Based Insights

The malaria treatment market is segmented based on treatment into prescription medications, vaccines, diagnostic tests, and others. The prescription medications are further segmented into chloroquine phosphate, artemisinin-based combination therapies (acts), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others. The diagnostic tests segment held the largest market share of US$ 685.69 million in 2021.

.

Drug Type-Based Insights

The malaria treatment market is bifurcated based on drug type into branded and generic. The generic segment accounted for a larger share of the market in 2021; however, the branded segment is expected to register a higher CAGR of 5.5% during the forecast period.

Route of Administration-Based Insights

Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment accounted for the largest share of the market in 2021; however, the parenteral & intravenous segment is expected to register the highest CAGR of 5.4% during the forecast period.

Distribution Channel-Based Insights

Based on distribution channels, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment accounted for the largest share of the market in 2021; however, the online pharmacies segment is expected to register the highest CAGR of 6.9% during the forecast period.

End User-Based Insights

Based on drug type, the malaria treatment market is categorized into hospitals, specialty clinics, home care, and others. The hospital’s segment accounted for the largest share of the market in 2021; however, the specialty clinics segment is expected to register the highest CAGR of 5.5% during the forecast period.

A few of the major primary and secondary sources referred to while preparing the report on the DVT preventive pump market are the World Health Organization (WHO), the US Census Bureau, and the US National Library of Medicine, among others.

Government and Private Sector's Initiatives to Raise Awareness About Malaria to Drive Global Malaria Treatment Market During 2022–2028

According to our latest study on "Malaria Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Treatment, Drug Type, Route of Administration, Distribution Channel, and End User," the market is expected to grow from US$ 1,638.27 million in 2021 to US$ 2,291.49 million by 2028; it is estimated to grow at a CAGR of 4.9% from 2022 to 2028. The market growth is primarily attributed to an increasing prevalence of malaria and government and private sector's initiatives to raise awareness about malaria. However, counterfeit antimalarial drugs and subsequent drug resistance are hindering the market growth.

Government and private sector’s initiative for raising awareness about malaria act as a standalone factor responsible for the influential growth of the overall malaria treatment market. Malaria awareness campaigns help enhance knowledge regarding the disease and improve behaviors promoting health, along with promoting intersectoral collaboration and social support. The WHO is responsible for coordinating the Global Malaria Programme (GMP) as part of its global efforts to control and eradicate malaria. The program is led by the "Global Technical Strategy for Malaria 2016–2030," which was adopted by the World Health Assembly in May 2015 and was further restructured in 2021. The WHO observes 25 April as World Malaria Day every year to highlight the collective energy and commitment of the malaria communities across the world in uniting for the common objective of freeing the world from malaria.

In 2016, India introduced its first National Framework for Malaria Elimination, which will be valid from 2016 through 2030. In 2019, the Indian government raised funding by more than 25% for the National Vector Borne Disease Control Programme, launched in 2003. The country has also increased its contribution as a donor to the Global Fund to Fight Malaria. Further, in the US, efforts for controlling malaria are made primarily through the President's Malaria Initiative (PMI), overseen by the US Global Malaria Coordinator. According to the Global Health Policy, the US planned the funding of ~US$ 1 billion in FY 2022 for malaria control and research activities. The goal of the US government under the PMI Strategy 2021–2026 is to manage malaria and reduce deaths caused by it, along with a long-term aim of eradicating the disease.

Several governments of various countries across the globe are taking initiatives to create awareness and conduct research for the development of new antimalarial drugs and vaccines. As per the WHO data, total funding for the control and elimination of malaria reached ~US$ 3 billion in 2019; governments of endemic countries, collectively, contributed 31% (~US$ 900 million) of the total fund to create awareness and development of new vaccines. Private companies are also engaging in the fight against malaria and investing heavily in R&D activities. For instance, in 2018, Novartis invested more than US$ 100 million to enhance its research and development activities for next-generation treatments by 2023.

Governments in countries with a high prevalence of malaria are deploying various strategies to eradicate the disease by improving access to treatment and helping communities in malaria-endemic countries in delivering better healthcare. A few of these initiatives are mentioned below.

• Myanmar has a national malaria control plan that is approved by the Global Fund, and it expects to eliminate the disease caused by P. falciparum by 2030. The universal healthcare coverage in the country includes access to malaria diagnosis by microscopy or rapid diagnostic tests (RDTs) and the availability of artemisinin-based combination therapies (ACTs).

• Thailand has implemented the National Strategic Plan for Malaria Elimination that applies an integrated elimination strategy for the elimination of the disease by 2024.

• In January 2020, the Corporate Alliance on Malaria in Africa (CAMA) launched a strategic plan for 2021–2023. This plan aims to reach millions of people with malaria control interventions and scale up prevention activities in the region.

• Abbott collaborated with “Malaria No More” (a nonprofit organization to eradicate malaria) and the Government of Odisha, India, to provide technology, expertise, and funding to facilitate advanced efforts to end malaria in the state. In January 2019, Abbott announced its plans to supply one million RDTs to strengthen Odisha's malaria diagnosis and surveillance system. The company also announced its plans to support “Malaria No More” with the financial aid of US$ 750,000 to support the malaria elimination strategy in the state.

Such initiatives by government and private companies to spread awareness about malaria and reinforce malaria eradication efforts are bolstering the malaria treatment market growth.

Impact of COVID-19 on Malaria Treatment Market

According to the World Health Organization (WHO) report, there were an estimated 241 million cases of malaria and 627,000 malarial deaths globally in 2020. Additionally, two-thirds of these additional deaths (47,000) were linked to disruptions in the provision of malaria prevention, diagnosis, and treatment during the COVID-19 pandemic. Also, during the initial days of the pandemic, severe service disruptions caused malarial deaths in Sub-Saharan Africa. As Sub-Saharan Africa continues to carry the heaviest malaria burden accounting for ~95% of all malaria cases and 96% of all deaths in 2020 as per the estimates provided by WHO. Therefore, WHO and its partners recognize the need to ensure better and more equitable access to all health services involving malaria prevention, diagnosis, and treatment. Moreover, innovative tools also played a vital role in the treatment of malaria during the pandemic. For example, "RTS,S/AS01 (RTS,S)" is a new malaria prevention tool. Further, the WHO recommended that children living in Sub-Saharan Africa must be screened for moderate to high infection of P. falciparum.

Rapid Diagnostic Tests (RDTs) to Bolster Malaria Treatment Market Growth

RDTs for malaria can improve the quality of management of the disease. RDTs are proven to be highly affordable and effective for public health programs implemented in low-resource settings. RDTs are widely used in remote areas with limited access to microscopy services. As a result, there has been a rapid rise in the demand for RDTs for malaria. Several RDTs have been developed to test the presence of malaria parasites in blood samples. Identifying and successfully treating malaria in low transmission areas is critical to reduce transmission and achieve complete elimination of the disease. According to the WHO, more than 70% of malaria diagnostic testing is performed using RDTs in Africa. Many companies are engaged in developing a wide range of RDTs with high sensitivities. A few of these developments are mentioned below.

• In November 2020, researchers from Rice University developed a simple microneedle patch similar to a bandage to detect malaria. With this development, the researchers have stepped on the path of reducing the burden of disease in countries struggling with poor health infrastructure. The microneedles loaded on the patch collect interstitial fluid, which contains several biomarkers that help in detecting malaria.

• In June 2020, the Foundation for Innovative New Diagnostics (FIND) and Scanwell Health, a US-based company, partnered to develop a smartphone app that uses machine learning to read RDTs for malaria. This app would help healthcare professionals to interpret and record test results. With the expected compatibility with RDT kits and mobile devices, the app is likely to receive significant attention in low- and middle-income countries.

Zydus Healthcare Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis AG, Cipla Ltd, Viatris Inc, Lupin Ltd, AdvaCare Pharma USA LLC, and VLP Therapeutics LLC are among the leading companies operating in the malaria treatment market.

Based on treatment, the malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. Based on drug type, the malaria treatment market is bifurcated into branded and generic. Based on route of administration, the malaria treatment market is bifurcated into oral and parenteral & intravenous. Based on distribution channel, the malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. Based on end user, the malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. By geography, the malaria treatment market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, Nigeria, Democratic Republic of Congo, United Republic of Tanzania, Mozambique, Uganda, Ghana, Burkina Faso, Kenya, Zambia, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Malaria Treatment Market – By Treatment

1.3.2 Global Malaria Treatment Market – By Drug Type

1.3.3 Global Malaria Treatment Market – By Route of Administration

1.3.4 Global Malaria Treatment Market – By Distribution Channel

1.3.5 Global Malaria Treatment Market – By End User

1.3.6 Global Malaria Treatment Market– By Geography

2. Global Malaria Treatment Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Malaria Treatment Market– Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe– PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East & Africa – PEST Analysis

4.2.5 South & Central America (SCAM) – PEST Analysis

4.3 Experts Opinion

5. Malaria Treatment market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Malaria

5.1.2 Government and Private Sector’s Initiatives to Raise Awareness About Malaria

5.2 Market Restraints

5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance

5.3 Market Opportunities

5.3.1 Extending Pipeline of New Drugs and Vaccines

5.4 Future Trends

5.4.1 Rapid Diagnostic Tests

5.5 Impact Analysis

6. Malaria Treatment Market– Global Analysis

6.1 Global Malaria Treatment Market Revenue Forecast and Analysis

6.1.1 Global Malaria Treatment Market Revenue Forecast and Analysis

6.1.2 Market Positioning of Key Players in Malaria Treatment Market

7. Malaria Treatment Market Analysis and Forecasts To 2028 – By Treatment

7.1 Overview

7.2 Global Malaria Treatment Market, By Treatment 2021 & 2028 (%)

7.3 Prescription Medications

7.3.1 Overview

7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)

7.3.3 Chloroquine Phosphate

7.3.3.1 Overview

7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)

7.3.4 Artemisinin- based Combination Therapies (ACTs)

7.3.4.1 Overview

7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)

7.3.5 Atovaquone-Proguanil

7.3.5.1 Overview

7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)

7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline

7.3.6.1 Overview

7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)

7.3.7 Primaquine Phosphate

7.3.7.1 Overview

7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)

7.3.8 Others

7.3.8.1 Overview

7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Vaccines

7.4.1 Overview

7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)

7.5 Diagnostic Tests

7.5.1 Overview

7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. Malaria Treatment Market Analysis and Forecasts To 2028 – By Drug Type

8.1 Overview

8.2 Global Malaria Treatment Market, By Drug Type 2021 & 2028 (%)

8.3 Branded

8.3.1 Overview

8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Generics

8.4.1 Overview

8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)

9. Malaria Treatment Market Analysis and Forecasts To 2028 – By Route of Administration

9.1 Overview

9.2 Global Malaria Treatment Market, By Delivery Mode 2021 & 2028 (%)

9.3 Oral

9.3.1 Overview

9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Parenteral and Intravenous Mode

9.4.1 Overview

9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)

10. Malaria Treatment Market Analysis and Forecasts To 2028 – By Distribution Channel

10.1 Overview

10.2 Global Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)

10.3 Direct Tender

10.3.1 Overview

10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)

10.4 Hospital Pharmacies

10.4.1 Overview

10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

10.5 Retail Pharmacies

10.5.1 Overview

10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

10.6 Online Pharmacies

10.6.1 Overview

10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

10.7 Others

10.7.1 Overview

10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

11. Malaria Treatment Market Analysis and Forecasts To 2028 – By End User

11.1 Overview

11.2 Global Malaria Treatment Market, By End User 2021 & 2028 (%)

11.3 Hospitals

11.3.1 Overview

11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)

11.4 Specialty Clinics

11.4.1 Overview

11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)

11.5 Homecare

11.5.1 Overview

11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)

11.6 Others

11.6.1 Overview

11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

12. Global Malaria Treatment Market – Geographic Analysis

12.1.1 North America: Malaria Treatment Market

12.1.2 Overview

12.1.3 North America: Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)

12.1.4 North America: Malaria Treatment Market, by Treatment, 2019–2028 (US$ Million)

12.1.4.1 North America: Malaria Treatment Market, by Prescription Medication, 2019–2028 (US$ Million)

12.1.5 North America: Malaria Treatment Market, by Drug Type, 2019–2028 (US$ Million)

12.1.6 North America: Malaria Treatment Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.7 North America: Malaria Treatment Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.8 North America: Malaria Treatment Market, by End user, 2019–2028 (US$ Million)

12.1.8.1 US: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.1.1 US: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.1.2 US: Malaria Treatment Market, by Treatment, 2019–2028 (US$ Million)

12.1.8.1.2.1 US: Malaria Treatment Market, by Prescription Medication, 2019–2028 (US$ Million)

12.1.8.1.3 US: Malaria Treatment Market, by Drug Type, 2019–2028 (US$ Million)

12.1.8.1.4 US: Malaria Treatment Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.8.1.5 US: Malaria Treatment Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.8.1.6 US: Malaria Treatment Market, by End User, 2019–2028 (US$ Million)

12.1.8.2 Canada: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.2.1 Canada: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.2.2 Canada: Malaria Treatment Market, by Treatment, 2019–2028 (US$ Million)

12.1.8.2.2.1 Canada: Malaria Treatment Market, by Prescription Medication, 2019–2028 (US$ Million)

12.1.8.2.3 Canada: Malaria Treatment Market, by Drug Type, 2019–2028 (US$ Million)

12.1.8.2.4 Canada: Malaria Treatment Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.8.2.5 Canada: Malaria Treatment Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.8.2.6 Canada: Malaria Treatment Market, by End User, 2019–2028 (US$ Million)

12.1.8.3 Mexico: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.3.1 Mexico: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.1.8.3.2 Mexico: Malaria Treatment Market, by Treatment, 2019–2028 (US$ Million)

12.1.8.3.2.1 Mexico: Malaria Treatment Market, by Prescription Medication, 2019–2028 (US$ Million)

12.1.8.3.3 Mexico: Malaria Treatment Market, by Drug Type, 2019–2028 (US$ Million)

12.1.8.3.4 Mexico: Malaria Treatment Market, by Route of Administration, 2019–2028 (US$ Million)

12.1.8.3.5 Mexico: Malaria Treatment Market, by Distribution Channel, 2019–2028 (US$ Million)

12.1.8.3.6 Mexico: Malaria Treatment Market, by End User, 2019–2028 (US$ Million)

12.2 Europe: Malaria Treatment Market

12.2.1 Overview

12.2.2 Europe: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.3 Europe: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

12.2.3.1 Europe: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.2.4 Europe: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

12.2.5 Europe: Malaria Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

12.2.6 Europe: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.2.7 Europe: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8 Europe: Malaria Treatment Market, by Country, 2021 & 2028 (%)

12.2.8.1 Germany: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.1 Overview

12.2.8.1.2 Germany: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.3 Germany: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.3.1 Germany: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.2.8.1.4 Germany: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.5 Germany: Malaria Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.6 Germany: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.2.8.1.7 Germany: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2 France: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.1 Overview

12.2.8.2.2 France: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.3 France: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.3.1 France: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.2.8.2.4 France: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.5 France: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.6 France: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.2.8.2.7 France: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3 UK: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.1 Overview

12.2.8.3.2 UK: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.3 UK: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.3.1 UK: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.2.8.3.4 UK: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.5 UK: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.6 UK: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.2.8.3.7 UK: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4 Italy: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.1 Overview

12.2.8.4.2 Italy: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.3 Italy: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.3.1 Italy: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.2.8.4.4 Italy: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.5 Italy: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.6 Italy: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.2.8.4.7 Italy: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5 Spain: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.1 Overview

12.2.8.5.2 Spain: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.3 Spain: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.3.1 Spain: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.2.8.5.4 Spain: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.5 Spain: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.6 Spain: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.2.8.5.7 Spain: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6 Rest of Europe: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.1 Overview

12.2.8.6.2 Rest of Europe: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.3 Rest of Europe: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.3.1 Rest of Europe: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.2.8.6.4 Rest of Europe: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.5 Rest of Europe: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.6 Rest of Europe: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.2.8.6.7 Rest of Europe: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.3 Asia Pacific Malaria Treatment Market Revenue and Forecasts To 2028

12.3.1 Overview

12.3.2 Asia Pacific Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.3 Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.3.3.1 Asia Pacific: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.3.4 Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

12.3.5 Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.3.6 Asia Pacific: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.3.7 Asia Pacific: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.3.8 Asia Pacific: Malaria Treatment Market, by Country, 2021 & 2028 (%)

12.3.8.1 Japan: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.8.1.1 Overview

12.3.8.1.2 Japan: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.8.1.3 Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.3.8.1.3.1 Japan: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.3.8.1.4 Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

12.3.8.1.5 Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.3.8.1.6 Japan: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.3.8.1.7 Japan: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.3.8.2 China: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.8.2.1 Overview

12.3.8.2.2 China: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.8.2.3 China: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.3.8.2.3.1 China: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.3.8.2.4 China: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

12.3.8.2.5 China: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.3.8.2.6 China: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.3.8.2.7 China: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.3.8.3 India Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.8.3.1 Overview

12.3.8.3.2 India: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.8.3.3 India: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.3.8.3.3.1 India: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.3.8.3.4 India: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

12.3.8.3.5 India: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.3.8.3.6 India: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.3.8.3.7 India: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.3.8.4 South Korea: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.8.4.1 Overview

12.3.8.4.2 South Korea: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.8.4.3 South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.3.8.4.3.1 South Korea: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.3.8.4.4 South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

12.3.8.4.5 South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.3.8.4.6 South Korea: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.3.8.4.7 South Korea: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.3.8.5 Australia: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.8.5.1 Overview

12.3.8.5.2 Australia: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.3.8.5.3 Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.3.8.5.3.1 Australia: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.3.8.5.4 Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

12.3.8.5.5 Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.3.8.5.6 Australia: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.3.8.5.7 Australia: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.3.8.6 Rest of Asia Pacific: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.3.8.6.1 Overview

12.3.8.6.2 Rest of Asia Pacific: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

12.3.8.6.3 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.3.8.6.3.1 Rest of Asia Pacific: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.3.8.6.4 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

12.3.8.6.5 Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

12.3.8.6.6 Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.3.8.6.7 Rest of Asia Pacific: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4 Middle East & Africa Malaria Treatment Market

12.4.1 Overview

12.4.2 Middle East & Africa Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.3 Middle East & Africa: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.3.1 Middle East & Africa: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.4 Middle East & Africa: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

12.4.5 Middle East & Africa: Malaria Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

12.4.6 Middle East & Africa: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.7 Middle East & Africa: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8 Middle East & Africa: Malaria Treatment Market, by Country, 2021 & 2028 (%)

12.4.8.1 UAE: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.1.1 Overview

12.4.8.1.2 UAE: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.1.3 UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.1.3.1 UAE: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.1.4 UAE: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.1.5 UAE: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.1.6 UAE: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.1.7 UAE: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.2 Saudi Arabia: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.2.1 Overview

12.4.8.2.2 Saudi Arabia Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.2.3 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.2.3.1 Saudi Arabia: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.2.4 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.2.5 Saudi Arabia: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.2.6 Saudi Arabia: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.2.7 Saudi Arabia: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.3 South Africa: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.3.1 Overview

12.4.8.3.2 South Africa Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.3.3 South Africa: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.3.3.1 South Africa: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.3.4 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.3.5 South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.3.6 South Africa: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.3.7 South Africa: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.4 Nigeria: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.4.1 Overview

12.4.8.4.2 Nigeria: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.4.3 Nigeria: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.4.3.1 Nigeria: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.4.4 Nigeria: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.4.5 Nigeria: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.4.6 Nigeria: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.4.7 Nigeria: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.5 The Democratic Republic of Congo: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.5.1 Overview

12.4.8.5.2 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.5.3 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.5.3.1 The Democratic Republic of Congo: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.5.4 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.5.5 The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.5.6 The Democratic Republic of Congo: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.5.7 The Democratic Republic of Congo: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.6 United Republic of Tanzania: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.6.1 Overview

12.4.8.6.2 United Republic of Tanzania Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.6.3 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.6.3.1 United Republic of Tanzania: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.6.4 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.6.5 United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.6.6 United Republic of Tanzania: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.6.7 United Republic of Tanzania: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.7 Mozambique: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.7.1 Overview

12.4.8.7.2 Mozambique: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.7.3 Mozambique: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.7.3.1 Mozambique: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.7.4 Mozambique: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.7.5 Mozambique: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.7.6 Mozambique: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.7.7 Mozambique: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.8 Uganda: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.8.1 Overview

12.4.8.8.2 Uganda Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.8.3 Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.8.3.1 Uganda: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.8.4 Uganda: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.8.5 Uganda: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.8.6 Uganda: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.8.7 Uganda: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.9 Ghana: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.9.1 Overview

12.4.8.9.2 Ghana Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.9.3 Ghana: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.9.3.1 Ghana: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.9.4 Ghana: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.9.5 Ghana: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.9.6 Ghana: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.9.7 Ghana: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.10 Burkina Faso: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.10.1 Overview

12.4.8.10.2 Burkina Faso Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.10.3 Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.10.3.1 Burkina Faso: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.10.4 Burkina Faso: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.10.5 Burkina Faso: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.10.6 Burkina Faso: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.10.7 Burkina Faso: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.11 Kenya: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.11.1 Overview

12.4.8.11.2 Kenya Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.11.3 Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.11.3.1 Kenya: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.11.4 Kenya: Malaria Treatment Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.11.5 Kenya: Malaria Treatment Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.11.6 Kenya: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.11.7 Kenya: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.12 Zambia: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.12.1 Overview

12.4.8.12.2 Zambia Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.12.3 Zambia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.12.3.1 Zambia: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.12.4 Zambia: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.12.5 Zambia: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.12.6 Zambia: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.12.7 Zambia: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.4.8.13 Rest of the Middle East and Africa: Malaria Treatment Market – Revenue and Forecast to 2028 (USD Million)

12.4.8.13.1 Overview

12.4.8.13.2 Rest of the Middle East and Africa Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

12.4.8.13.3 Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

12.4.8.13.3.1 Rest of Middle East & Africa: Malaria Treatment Market, by Prescription Medication, 2020–2028 (US$ Million)

12.4.8.13.4 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Drug Type (US$ Million)

12.4.8.13.5 Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts To 2028, By Route of Administration (US$ Million)

12.4.8.13.6 Rest of Middle East & Africa: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

12.4.8.13.7 Rest of Middle East & Africa: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

12.5 South & Central America: Malaria Treatment Market Revenue and Forecasts To 2028

12.5.1 Overview

12.5.2 South & Central America: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

12.5.3 South & Central America: Malaria Treatment Market, by Treatment, 2019 – 2028 (US$ Million)

12.5.3.1 South & Central America: Malaria Treatment Market, by Prescription Medication, 2019 – 2028 (US$ Million)

12.5.4 South & Central America: Malaria Treatment Market, by Drug Type, 2019 – 2028 (US$ Million)

12.5.5 South & Central America: Malaria Treatment Market, by Route of Administration, 2019 – 2028 (US$ Million)

12.5.6 South & Central America: Malaria Treatment Market, by Distribution Channel, 2019 – 2028 (US$ Million)

12.5.7 South & Central America: Malaria T

LIST OF TABLES.

Table 1. North America Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 2. North America Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 3. North America Malaria Treatment Market, by Drug Type – Revenue and Forecast to 2028 (US$ Million)

Table 4. North America Malaria Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 5. North America Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 6. North America Malaria Treatment Market, by End user – Revenue and Forecast to 2028 (US$ Million)

Table 7. US Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 8. US Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 9. US Malaria Treatment Market, by Drug Type – Revenue and Forecast to 2028 (US$ Million)

Table 10. US Malaria Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 11. US Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 12. US Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13. Canada Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 14. Canada Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 15. Canada Malaria Treatment Market, by Drug Type – Revenue and Forecast to 2028 (US$ Million)

Table 16. Canada Malaria Treatment Market, by Route of Adminstration – Revenue and Forecast to 2028 (US$ Million)

Table 17. Canada Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 18. Canada Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19. Mexico Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 20. Mexico Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 21. Mexico Malaria Treatment Market, by Drug Type – Revenue and Forecast to 2028 (US$ Million)

Table 22. Mexico Malaria Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 23. Mexico Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 24. Mexico Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 25. Europe: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 26. Europe: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 27. Europe: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 28. Europe: Malaria Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 29. Europe: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 30. Europe: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 31. Germany: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 32. Germany: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 33. Germany: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 34. Germany: Malaria Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 35. Germany: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 36. Germany: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 37. France: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 38. France: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 39. France: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 40. France: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 41. France: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 42. France: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 43. UK: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 44. UK: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 45. UK: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 46. UK: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 47. UK: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 48. UK: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 49. Italy: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 50. Italy: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 51. Italy: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 52. Italy: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 53. Italy: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 54. Italy: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 55. Spain: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 56. Spain: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 57. Spain: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 58. Spain: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 59. Spain: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 60. Spain: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 61. Rest of Europe: Malaria Treatment Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 62. Rest of Europe: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 63. Rest of Europe: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 64. Rest of Europe: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 65. Rest of Europe: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 66. Rest of Europe: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 67. Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million).

Table 68. Asia Pacific: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 69. Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 70. Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 71. Asia Pacific: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 72. Asia Pacific: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 73. Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 74. Japan: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 75. Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 76. Japan: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 77. Japan: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 78. Japan: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 79. China: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 80. China: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 81. China: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 82. China: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 83. China: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 84. China: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 85. India: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 86. India: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 87. India: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 88. India: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 89. India: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 90. India: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 91. South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 92. South Korea: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 93. South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 94. South Korea: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 95. South Korea: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 96. South Korea: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 97. Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 98. Australia: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 99. Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 100. Australia: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 101. Australia: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 102. Australia: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 103. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 104. Rest of Asia Pacific: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 105. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 106. Rest of Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 107. Rest of Asia Pacific: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 108. Rest of Asia Pacific: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 109. Middle East & Africa: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 110. Middle East & Africa: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 111. Middle East & Africa: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 112. Middle East & Africa: Malaria Treatment Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 113. Middle East & Africa: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 114. Middle East & Africa: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 115. UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 116. UAE: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 117. UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 118. UAE: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 119. UAE: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 120. UAE: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 121. Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 122. Saudi Arabia: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 123. Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 124. Saudi Arabia: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 125. Saudi Arabia: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 126. Saudi Arabia: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 127. South Africa Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 128. South Africa: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 129. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 130. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 131. South Africa: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 132. South Africa: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 133. Nigeria Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 134. Nigeria: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 135. Nigeria: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 136. Nigeria: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 137. Nigeria: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 138. Nigeria: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 139. The Democratic Republic of Congo Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 140. The Democratic Republic of Congo: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 141. The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 142. The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 143. The Democratic Republic of Congo: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 144. The Democratic Republic of Congo: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 145. United Republic of Tanzania Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 146. United Republic of Tanzania: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 147. United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 148. United Republic of Tanzania: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 149. United Republic of Tanzania: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 150. United Republic of Tanzania: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 151. Mozambique Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 152. Mozambique: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 153. Mozambique: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 154. Mozambique Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 155. Mozambique: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 156. Mozambique: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 157. Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 158. Uganda: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 159. Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 160. Uganda: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 161. Uganda: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 162. Uganda: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 163. Ghana: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 164. Ghana: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 165. Ghana: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 166. Ghana: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 167. Ghana: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 168. Ghana: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 169. Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 170. Burkina Faso: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 171. Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 172. Burkina Faso: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 173. Burkina Faso: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 174. Burkina Faso: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 175. Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 176. Kenya: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 177. Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 178. Kenya: Malaria Treatment Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 179. Kenya: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 180. Kenya: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 181. Zambia: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 182. Zambia: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 183. Zambia: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 184. Zambia: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 185. Zambia: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 186. Zambia: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 187. Rest of Middle East & Africa: Malaria Treatment Market Revenue and Forecasts to 2028, By Treatment (US$ Million)

Table 188. Rest of Middle East & Africa: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 189. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Drug Type (US$ Million)

Table 190. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Route of Administration (US$ Million)

Table 191. Rest of Middle East & Africa: Malaria Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 192. Rest of Middle East & Africa: Malaria Treatment Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 193. South & Central America: Malaria Treatment Market, by Treatment– Revenue and Forecast to 2028 (US$ Million).

Table 194. South & Central America: Malaria Treatment Market, by Prescription Medication – Revenue and Forecast to 2028 (US$ Million)

Table 195. South & Central America: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 196. South & Central America: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 197. South & Central America: Malaria Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 198. South & Central America: Malaria Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 199. Brazil: Malaria Treatment Market, by Treatment– Revenue and Forecast to 2028 (US$ Million)

Table 200. Brazil: Malaria Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 201. Brazil: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 202. Brazil: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 203. Brazil: Malaria Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 204. Brazil: Malaria Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 205. Argentina: Malaria Treatment Market, by Treatment– Revenue and Forecast to 2028 (US$ Million)

Table 206. Argentina: Malaria Treatment Market, by Prescription Medications – Revenue and Forecast to 2028 (US$ Million)

Table 207. Argentina: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 208. Argentina: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 209. Argentina: Malaria Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 210. Argentina: Malaria Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 211. Rest of South & Central America: Malaria Treatment Market, by Treatment– Revenue and Forecast to 2028 (US$ Million)

Table 212. Rest of South & Central America: Malaria Treatment Market, by Prescription Medications – Revenue and Forecast to 2028 (US$ Million)

Table 213. Rest of South & Central America: Malaria Treatment Market, by Drug Type– Revenue and Forecast to 2028 (US$ Million)

Table 214. Rest of South & Central America: Malaria Treatment Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 215. Rest of South & Central America: Malaria Treatment Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Million)

Table 216. Rest of South & Central America: Malaria Treatment Market, by End User– Revenue and Forecast to 2028 (US$ Million)

Table 217. Recent Inorganic Growth Strategies in the Malaria Treatment Market

Table 218. Recent Organic Growth Strategies in the Malaria Treatment Market

Table 219. Glossary of Terms, Malaria Treatment Market

LIST OF FIGURES.

Figure 1. Malaria Treatment Market Segmentation

Figure 2. Malaria Treatment Segmentation, By Region

Figure 3. Global Malaria Treatment Market Overview

Figure 4. Oral Held the Largest Share of the Route of Administration Segment in Malaria Treatment Market

Figure 5. Asia Pacific to Show Significant Growth During Forecast Period

Figure 6. Malaria Treatment Market, by Geography (US$ Million)

Figure 7. Global Malaria Treatment Market, Industry Landscape

Figure 8. North America PEST Analysis

Figure 9. Europe and PEST Analysis

Figure 10. Asia Pacific PEST Analysis

Figure 11. Middle East & Africa PEST Analysis

Figure 12. South & Central America (SCAM) PEST Analysis

Figure 13. Malaria Treatment Market impact analysis of driver and restraints

Figure 14. Global Malaria Treatment Market – Revenue Forecast and Analysis – 2020- 2028

Figure 15. Global Malaria Treatment Market – Revenue Forecast and Analysis – 2022- 2028

Figure 16. Global Malaria Treatment Market, by Treatment 2021 & 2028 (%)

Figure 17. Prescription Medication Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18. Chloroquine Phosphate Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. Atovaquone-Proguanil Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22. Primaquine Phosphate Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23. Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24. Vaccines Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25. Diagnostic Tests Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26. Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27. Global Malaria Treatment Market, by Drug Type 2021 & 2028 (%)

Figure 28. Branded Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 29. Generics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30. Global Malaria Treatment Market, by Delivery Mode 2021 & 2028 (%)

Figure 31. Oral Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32. Parenteral and Intravenous Mode Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33. Global Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)

Figure 34. Direct Tender Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35. Hospital Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 36. Retail Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 37. Online Pharmacies Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 38. Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 39. Global Malaria Treatment Market, by End User 2021 & 2028 (%)

Figure 40. Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 41. Independent Labs Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 42. Homecare Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 43. Physician Office Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 44. North America: Malaria Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 45. North America Malaria Treatment Market Revenue and Forecast to 2028 (USD Million)

Figure 46. North America: Malaria Treatment Market, by Country, 2021 & 2028 (%)

Figure 47. US: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 48. Canada: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 49. Mexico: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 50. Europe: Malaria Treatment Market, by Key Country – Revenue (2021) (US$ Million)

Figure 51. Europe: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 52. Europe: Malaria Treatment Market, by Country, 2021 & 2028 (%)

Figure 53. Germany: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 54. France: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 55. UK: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 56. Italy: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 57. Spain: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 58. Rest of Europe: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 59. Asia Pacific Malaria Treatment Market Overview, by Country (2021)

Figure 60. Asia Pacific: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 61. Asia Pacific: Malaria Treatment Market, by Country, 2021& 2028 (%)

Figure 62. Japan: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 63. China: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 64. India: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 65. South Korea: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 66. Australia: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 67. Rest of Asia Pacific: Malaria Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 68. Middle East & Africa Malaria Treatment Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 69. Middle East & Africa Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 70. Middle East & Africa: Malaria Treatment Market, by Country, 2021 & 2028 (%)

Figure 71. UAE: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 72. Saudi Arabia: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 73. South Africa: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 74. Nigeria: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 75. The Democratic Republic of Congo: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 76. United Republic of Tanzania: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 77. Mozambique: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 78. Uganda: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 79. Ghana: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 80. Burkina Faso: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 81. Kenya: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 82. Zambia: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 83. Rest of the Middle East and Africa: Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

Figure 84. South & Central America: Malaria Treatment Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 85. South & Central America: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 86. South & Central America Malaria Treatment Market, by Country, 2021 & 2028 (%)

Figure 87. Brazil: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 88. Argentina: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 89. Rest of South & Central America: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 90. Impact of COVID-19 Pandemic on Malaria Treatment Market in North American Countries

Figure 91. Impact of COVID-19 Pandemic in European Country Markets

Figure 92. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 93. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 94. Impact of COVID-19 Pandemic on Malaria Treatment Market in SACM

Figure 95. Growth Strategies in the Malaria Treatment Market, 2021-2028

The List of Companies - Malaria Treatment Market

• Novartis

• GSK plc

• Zydus Cadila

• Sanofi SA

• Advacare Pharma USA LLC

• Lupin Ltd

• Viatris

• Cipla Ltd

• VLP Therapeutics

• Sun Pharmaceutical Industries Ltd

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the malaria treatment market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the global malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TOP